Adare acquires Orbis for drug discovery May 4, 2020 -- Adare Pharmaceuticals on April 30 acquired pharmaceutical technology firm Orbis Biosciences. Financial details were not disclosed. The acquisition will enhance Adare's ability to manufacture products for the global pharmaceutical, animal health, and over-the-counter markets.
AbCellera secures COVID-19 drug development funding May 4, 2020 -- AbCellera Biologics has secured $175.6 million Canadian ($124.7 million U.S.) from the Canadian government's Innovation, Science, and Economic Development Strategic Innovation Fund to advance its efforts to discover antibodies for use in antiviral COVID-19 drugs.
FDA issues EUA for remdesivir to treat severe COVID-19 cases May 4, 2020 -- The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the investigational antiviral drug remdesivir to be used for the treatment of COVID-19. The EUA was issued to Gilead Sciences on Friday, May 1.
Trio, Ajinomoto to develop cancer therapeutic May 1, 2020 -- Cancer therapeutics company Trio Pharmaceuticals and biopharmaceutical contract development and manufacturing company Ajinomoto Bio-Pharma Services have announced a partnership to develop cancer therapeutics.
Kedrion, Kamada partner to combat COVID-19 April 29, 2020 -- Biopharmaceutical firms Kedrion Biopharma and Kamada are collaborating on the creation and clinical distribution of a plasma-derived anti-SARS-CoV-2 treatment product.